miR-128 significantly reduced hnRNPA1 in all but the lung cancer cell line and anti-miR-128 showed substantially enhanced hnRNPA1 levels in all cell lines except the teratoma cell line, see Figure 2D. Finally, as expected, miR-128 was determined to also significantly regulate hnRNPA1 protein levels in three additional cancer cell lines (A549 (lung cancer), SW620 (colon cancer) and PANC1 (pancreatic cancer)), see Figure 2E, quantifications are shown below each western blot result. The gene discussed is HNRNPA1; the disease is malignant colon neoplasm.